|
⚲
|
| Keyboard |
| Intellia Therapeutics Inc | |
|---|---|
| Ticker | NTLA |
| CIK # | 0001652130 |
| CUSIP | 45826J105 |
| Sector | Life Sciences - In Vitro & In Vivo Diagnostic Substances |
| Address | 130 Brookline Street Suite 201, Cambridge, MA 02139 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Intellia Therapeutics Inc | 2015-09-03 | 70.0 M | Exemption: 506(b) · Duration: One year or less · Commission: $2,341,029 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001652130] | 10-K | |
| [0001652130] | 10-Q | |
| [0001652130] | 3 | |
| [0001652130] | 4 | |
| [0001652130] | 5 | |
| [0001652130] | 8-K | |
| [0001652130] | D | |
| [0001652130] | SC 13D | |
| [0001652130] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Clark Eliana
Common Stock
|
2026-03-02 | Sell | 607 | $13.78 | 8,364 |
|
Basta James
Common Stock
|
2026-03-02 | Sell | 1,211 | $13.78 | 16,688 |
|
Leonard John M
Stock Option (right to buy) · derivative
|
2026-03-01 | Grant | 225,400 | $0.00 | |
|
Basta James
Common Stock
|
2026-03-01 | Grant | 46,080 | $0.00 | |
|
Dulac Edward J III
Common Stock
|
2026-03-01 | Grant | 61,280 | $0.00 | |
|
Lebwohl David
Stock Option (right to buy) · derivative
|
2026-03-01 | Grant | 14,204 | $0.00 | |
|
Dulac Edward J III
Stock Option (right to buy) · derivative
|
2026-03-01 | Grant | 87,543 | $0.00 | |
|
Schultes Birgit C
Common Stock
|
2026-03-01 | Grant | 39,200 | $0.00 | |
|
Clark Eliana
Common Stock
|
2026-03-01 | Grant | 7,353 | $0.00 | |
|
Clark Eliana
Stock Option (right to buy) · derivative
|
2026-03-01 | Grant | 10,505 | $0.00 | |
|
Dube Michael P
Common Stock
|
2026-03-01 | Grant | 17,250 | $0.00 | |
|
Schultes Birgit C
Stock Option (right to buy) · derivative
|
2026-03-01 | Grant | 56,000 | $0.00 | |
|
Lebwohl David
Common Stock
|
2026-03-01 | Grant | 9,943 | $0.00 | |
|
Leonard John M
Common Stock
|
2026-03-01 | Grant | 156,400 | $0.00 | |
|
Basta James
Stock Option (right to buy) · derivative
|
2026-03-01 | Grant | 65,829 | $0.00 | |
|
Leonard John M
Common Stock
|
2026-01-05 | Sell | 34,146 | $9.21 | 314,485 |
|
Basta James
Common Stock
|
2026-01-05 | Sell | 10,397 | $9.21 | 95,756 |
|
Dube Michael P
Common Stock
|
2026-01-05 | Sell | 2,989 | $9.21 | 27,529 |
|
Schultes Birgit C
Common Stock
|
2026-01-05 | Sell | 8,508 | $9.21 | 78,359 |
|
Cohen Fred E
Common Stock
|
2026-01-05 | Buy | 150,000 | $9.35 | 1,402,500 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 309 | 115,395,742 |
| 2025-12-31 | 297 | 108,817,224 |
| 2025-09-30 | 291 | 109,473,063 |
| 2025-06-30 | 282 | 102,552,683 |
| 2025-03-31 | 298 | 102,677,495 |
| 2024-12-31 | 295 | 100,836,220 |
| 2024-09-30 | 285 | 94,415,226 |
| 2024-06-30 | 295 | 90,842,774 |
| 2024-03-31 | 286 | 96,674,694 |
| 2023-12-31 | 297 | 87,983,953 |
| 2023-09-30 | 288 | 78,928,989 |
| 2023-06-30 | 295 | 76,905,206 |